Safety And Efficacy Study Of Topic Mucopolysaccharide Polysulfate Cream In The Superficial Varicose Veins Treatment

Inclusion Criteria: * Patients must be able to understand the study procedures, agree to participate, and give written consent. * Patients must be able to follow the study medication regimen. * Patients with inflammatory process in superficial veins for more than 72 hours. * Presence of symmetric lesions to compare one side to the other. Exclusion Criteria: * Pregnancy or risk of pregnancy. * Lactation. * Use of topical or systemic anti-inflammatory, antihistamine or immunosuppressive drugs within the last 48 hours prior to the study * Any alteration at other deep veins. * History of atopy or allergic diseases. * History of allergy to any component of the formulations. * Other conditions considered by the investigator as reasonable for non-eligibility